Many newly approved therapies are high in cost and distributed through restricted or REMS-controlled channels, making access for clinical research challenging.

Specialty PharmaSource sources REMS and specialty medications through a compliant, trusted partner network, managing required documentation and secure logistics to ensure reliable, confidential delivery. When necessary, we support access strategies aligned with the CREATES Act to facilitate procurement of reference products for bioequivalence and development programs.